21149 ⎘
Medicinal preparations containing antigens or antibodies; Antibodies ; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
COMPOSITIONS AND METHODS INCLUDING A RECOMBINANT HUMAN MAB THAT PROMOTES CNS REMYELINATION
#302Use of inactivated nonreplicating modified vaccinia virus Ankara (MVA) as monoimmunotherapy or in combination with immune checkpoint blocking agents for solid tumors
#303Method of enriching a target nucleic acid at a TNFRSF1B gene locus in a sample from a subject with inflammatory bowel disease
#304METHODS OF TREATING TRANSPLANT REJECTION USING A DOMAIN ANTIBODY DIRECTED AGAINST CD40L
#305Anti-CTLA4 monoclonal antibody or its antigen binding fragments, pharmaceutical compositions and uses
#306Localized immunosuppression of allografts for peripheral nerve repair
#307Compositions and methods for inducing humoral and cellular immunities against tumors and cancer
#308Compositions and methods for detecting prostate cancer
#309Polypeptides
#310ANTIBODY FORMULATIONS
#311Combination therapies of HDAC inhibitors and PD-1 inhibitors
#312Method of treating cancer using a combination of entinostat and an anti-CSF-1R antibody
#313TREATMENT WITH ANTI-VEGF ANTIBODIES
#314Methods of treating inflammatory and autoimmune diseases with natalizumab
#315Functionalized Prussian blue nanoparticles, combination Prussian blue nanoparticle-based nano-immunotherapy and applications thereof
#316Methods and Compositions for Dectin-2 Stimulation and Cancer Immunotherapy
#317Reducing systemic regulatory t cell levels or activity for treatment of disease and injury of the CNS
#318Reducing systemic regulatory T cell levels or activity for treatment of a retinal degeneration disorder
#319ANTIBODIES TO OPGL
#320Pharmaceutical composition for prevention and/or treatment of atopic dermatitis comprising IL-31 antagonist as active ingredient
#321Methods and compositions for enhancing the potency of superantigen mediated cancer immunotherapy
#322VITRO CELL CULTURE METHODS FOR BETA-THALASSEMIA USING ACTIVIN TYPE II RECEPTOR LIGAND TRAPS
#323ANTICANCER COMBINATION THERAPY
#324Kit for monitoring, detecting and staging GVHD
#325Method for high throughput peptide-MHC affinity screening for TCR ligands
#326HIGH-CONCENTRATION MONOCLONAL ANTIBODY FORMULATIONS
#327CD200R agonist antibodies and uses thereof
#328Methods and compositions for enhancing the potency of superantigen mediated cancer immunotherapy
#329Combination therapy using C-C chemokine receptor 4 (CCR4) antagonists and one or more immune checkpoint inhibitors
#330Compounds and methods for treating cancer
#331Anti-CD3 antibodies and uses thereof
#332Tumor treatment method with an individualized peptide vaccine
#333Human antibodies to GFRα3 and methods of making thereof
#334Drug delivery compositions and uses thereof
#335VIRAL DELIVERY OF NEOANTIGENS
#336PREVENTIVE OR THERAPEUTIC AGENT FOR HTLV-1 ASSOCIATED MYELOPATHY USING LOW-DOSE OF ANTI-CCR4 ANTIBODY
#337THERAPIES BASED ON CONTROL OF REGULATORY T CELL STABILITY AND FUNCTION VIA A NEUROPILIN-1:SEMAPHORIN AXIS
#338Methods of treating skin cancer by administering a PD-1 inhibitor
#339Combination immune therapy and cytokine control therapy for cancer treatment
#340METHOD OF ADMINISTERING AN ANTIBODY
#341Compositions and methods for the removal of biofilms
#342METHOD FOR PROVIDING OCULAR NEUROPROTECTION OR FOR PREVENTING, TREATING OR ALLEVIATING THE EFFECTS OF, AN OCULAR DISEASE ASSOCIATED WITH RETINAL GANGLION CELL DEATH
#343Drug delivery compositions and uses thereof
#344Combined organ and hematopoietic cells for transplantation tolerance of grafts
#345Transgenic mouse expressing amyloid precursor protein that has olfactory neuron degeneration
#346ErbB2 signaling and nerve regeneration
#347Compositions and methods for inhibiting arginase activity
#348COMBINATION OF RAMUCIRUMAB AND MERESTINIB FOR USE IN TREATMENT OF COLORECTAL CANCER
#349Combined organ and hematopoietic cells for transplantation tolerance of grafts
#350Compositions and methods of modulating anti-tumor immunity
#351INTRATUMORAL VEIN-FORMATION PROMOTING AGENT
#352METHOD OF ACTIVATING DENDRITIC CELLS
#353Agonistic antibodies that bind CD40
#354Combination comprising immunostimulatory oligonucleotides
#355Methods of treating inflammatory and autoimmune diseases with natalizumab
#356Anti-TIGIT antibodies
#357Vaccines against HPV and HPV-related diseases
#358EP4 inhibitors and use thereof
#359Bispecific Polypeptides to GITR and CTLA-4
#360METHODS OF USING INTERLEUKIN-10 FOR TREATING DISEASES AND DISORDERS
#361Combined organ and hematopoietic cells for transplantation tolerance of grafts
#362Bispecific CXCR4-CD4 polypeptides with potent anti-HIV activity
#363Compositions and methods for treating clostridium difficile infection
#364DR5 RECEPTOR AGONIST COMBINATIONS
#3652,3-Disubstituted pyridine compounds as TGF-β inhibitors and methods of use
#366ANTIGEN BINDING PROTEINS
#367Anti-Tim-3 antibodies for combination with anti-PD-1 antibodies
#368Methods and compositions for treating melanoma
#369CAMK2D antisense oligonucleotides and uses thereof
#370Benzamide and active compound compositions and methods of use
#371COMPOSITIONS AND METHODS OF TREATING CANCER
#372CD47 blockade therapy by HDAC inhibitors
#373NOVEL IMMUNOTHERAPEUTIC TREATMENTS FOR TUMOURS
#374GLA monotherapy for use in cancer treatment
#375Bispecific and monospecific antibodies using novel anti-PD-1 sequences
#376CD80 and CD86 binding protein compositions and uses thereof
#377Binding molecules binding PD-L1 and LAG-3
#378Methods of treating hematologic cancers
#379Gene editing methods and compositions for eliminating risk of JC virus activation and PML (progressive multifocal leukoencephalopathy) during immunosuppressive therapy
#380Monoclonal antibody and a method of use for the treatment of lupus
#381BISPECIFIC FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
#382Treatment Of IgE-Mediated Diseases With Antibodies That Specifically Bind CD38
#383ISOFORM-SPECIFIC, CONTEXT-PERMISSIVE TGFB1 INHIBITORS AND USE THEREOF
#384Immunomodulation after locoregional anti-tumoral treatment
#385Adenovirus and immunomodulator combination therapy
#386Methods of sensitizing cancer to immunotherapy
#387Combined organ and hematopoietic cells for transplantation tolerance of grafts
#388Combined organ and hematopoietic cells for transplantation tolerance of grafts
#389Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
#390Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells
#391Drug delivery compositions and uses thereof
#392Nucleic acid molecules encoding antibodies to the human glucagon receptor
#393Depletion of plasmacytoid dendritic cells
#394COMPOSITIONS AND METHODS FOR THE TREATMENT OF HUMAN PAPILLOMAVIRUS (HPV)-ASSOCIATED DISEASES
#395Method of eliminating hematopoietic stem cells/hematopoietic progenitors (HSC/HP) in a patient using bi-specific antibodies
#396Therapeutic compositions and methods with cytokine signaling immunomodulators
#397Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor
#398Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
#399MODIFIED CHIMERIC RECEPTORS AND USES THEREOF IN IMMUNE THERAPY
#400Compositions and methods for CD20 immunotherapy
#401Combined organ and hematopoietic cells for transplantation tolerance of grafts
#402Method of treating cancer with a biomaterial and a toll-like receptor agonist
#403IMMUNOSTIMULATORY COMBINATIONS
#404Combined organ and hematopoietic cells for transplantation tolerance of grafts
#405Combination cancer therapy
#406Compositions and methods for immune-mediated cancer therapy
#407IL-2 superagonists in combination with anti-PD-1 antibodies
#408Antigen binding proteins that bind PD-L1
#409Nanoparticles, controlled-release dosage forms, and methods for delivering an immunotherapeutic agent
#410Methods of treating cancer cells expressing tumor-associated integrins
#411Method for treating cancer
#412Anti-tumor agent containing immunomodulator, and antitumor effect potentiator
#413Methods and compositions for treatment of amyloid deposition diseases
#414Use of trans-[tetrachlorobis(1H-indazole)ruthenate(III)] for the treatment of cancer
#415Combination Therapies Employing GITR Binding Molecules
#416MODULATION OF YEAST-BASED IMMUNOTHERAPY PRODUCTS AND RESPONSES
#417Localized immunosuppression of allografts for peripheral nerve repair
#418Localized immunosuppression of allografts for peripheral nerve repair
#419METHOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS
#420Methods and compositions for treating multiple sclerosis
#421Ameliorating systemic sclerosis with death receptor agonists
#422Combined organ and hematopoietic cells for transplantation tolerance of HLA mismatched grafts
#423Drug combination and its use in therapy
#424Methods and Compositions for Treating Conditions of the Eye
#425Compositions and methods for inhibiting arginase activity
#426Combination therapies of HDAC inhibitors and PD-1 inhibitors
#427METHODS AND COMPOSITIONS FOR TREATING DISORDERS ASSOCIATED WITH PATHOLOGICAL NEOVASCULARIZATION
#428Combination therapy including tumor associated antigen binding antibodies
#429COMPOSITION FOR BLOCKING ANGIOGENESIS
#430TREATMENT OF NEUROINFLAMMATORY DISEASE
#431Anti-cancer combination therapy
#432Polynucleotides encoding anti-CD40 antibodies
#433Il-2Rβ-selective agonists in combination with an anti-CTLA-4 antibody or an anti-PD-1 antibody
#434Combined organ and hematopoietic cells for transplantation tolerance of grafts
#435RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY
#436Trispecific molecule combining specific tumor targeting and local immune checkpoint inhibition
#437Methods of treating and predicting non-response to anti-TNF treatment in subjects with inflammatory bowel disease
#438Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof
#439Regulatory T cell PD-1 modulation for regulating T cell effector immune responses
#440T-Cell Recepter (TCR) Targeting Therapies for Immune-Mediated Adverse Drug Reactions (ADRs) and Other Conditions
#441Combination treatment
#442The Methods For Treatment Of Tumors
#443Combination of a PD-1 Axis Binding Antagonist and an ALK Inhibitor for Treating ALK-Negative Cancer
#444ANTI-HRS ANTIBODIES AND COMBINATON THERAPIES FOR TREATING CANCERS
#445Anti-cancer vaccine combination
#446Anti-TIGIT anibodies, anti-PVRIG antibodies and combinations thereof
#447Compositions and methods for combating drug-resistant cancers
#448Dosage regimen for MAdCAM antagonists
#449Binding molecules with modified J-chain
#450Pharmaceutical compositions comprising humanized anti-CCR4 IgG4 antibody
#451Immunological reagents
#452IMMUNOGLOBULIN-LIKE MOLECULES DIRECTED AGAINST FIBRONECTIN-EDA
#453Combination comprising immunostimulatory oligonucleotides
#454Antibody Fragments Against the Insulin Receptor and Uses Thereof to Treat Hypoglycemia
#455Anti-Tim-3 antibodies, compositions comprising anti-Tim-3 antibodies and methods of making and using anti-Tim-3 antibodies
#456COMPOSITIONS AND METHODS OF ENHANCING ANTI-TUMOR RESPONSE USING HYBRID NEUTROPHILS
#457ANTIBODIES TO POLYPHOSPHATE DECREASE CLOT FORMATION, DECREASE INFLAMMATION, AND IMPROVE SURVIVAL
#458Combined organ and hematopoietic cells for transplantation tolerance of grafts
#459METHOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS
#460Use of inactivated nonreplicating modified vaccinia virus Ankara (MVA) as monoimmunotherapy or in combination with immune checkpoint blocking agents for solid tumors
#461COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO PD-1
#462ANTIBODY FORMULATIONS
#463METHODS TO ALTER THE TUMOR MICROENVIRONMENT FOR EFFECTIVE CANCER IMMUNOTHERAPY
#464Combined organ and hematopoietic cells for transplantation tolerance of grafts
#465Combined organ and hematopoietic cells for transplantation tolerance of grafts
#466METHODS FOR CANCER AND IMMUNOTHERAPY USING PRODRUGS OF GLUTAMINE ANALOGS
#467Methods and compositions for treating metabolic reprogramming disorders
#468PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF CANCER
#469MODULATION OF SRPX2-MEDIATED ANGIOGENESIS
#470NON-GENOTOXIC CONDITIONING REGIMEN FOR STEM CELL TRANSPLANTATION
#471Anti-KIR antibodies, formulations, and uses thereof
#472ISOFORM-SPECIFIC, CONTEXT-PERMISSIVE TGFB1 INHIBITORS AND USE THEREOF
#473COMBINATION THERAPIES FOR TREATING CANCERS
#474Humanized anti-CD79b antibodies and immunoconjugates and methods of use
#475Combined organ and hematopoietic cells for transplantation tolerance of grafts
#476Combined organ and hematopoietic cells for transplantation tolerance of grafts
#477Methods and compositions for combination immunotherapy
#478Compositions and Methods including a Recombinant Human MAB that Promotes CNS Remyelination
#479METHODS OF TREATING AUTOIMMUNE AND ALLOIMMUNE DISORDERS
#480Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof
#481GM-CSF/CD40L vaccine and checkpoint inhibitor combination therapy
#482In vitro cell culture methods for beta-thalassemia using activin type II receptor ligand traps
#483Bispecific molecules comprising an HIV-1 envelope targeting arm
#484Method of averting opioid addiction
#485COMBINATIONS OF PFKFB3 INHIBITORS AND IMMUNE CHECKPOINT INHIBITORS TO TREAT CANCER
#486Gene editing methods and compositions for eliminating risk of JC virus activation and PML (progressive multifocal leukoencephalopathy) during immunosuppressive therapy
#487Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy
#488Using targeted radiotherapy (TRT) to drive anti-tumor immune response to immunotherapies
#489Polypeptides
#490Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease
#491Multi-valent hepatitis B virus antigen binding molecules and uses thereof
#492Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
#493Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease
#494Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease
#495Hydrogel compositions and drug delivery systems comprising the same
#496TGFbeta Receptor II Antibodies
#497Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease
#498Bispecific CXCR4-CD4 polypeptides with potent anti-HIV activity
#499INTEGRIN BETA7 ANTAGONISTS AND METHODS OF TREATING CROHN'S DISEASE
#500Pharmaceutical composition for prevention and/or treatment of atopic dermatitis comprising IL-31 antagonist as active ingredient
#501Combination of HDAC inhibitor and anti-PD-1 antibody for treatment of cancer
#502Compositions and Methods for Identifying and Modulating Metabolic Health
#503Nucleic acids encoding agonistic antibodies that bind CD40
#504METHODS OF TREATING MENINGIOMA
#505MASKED ANTI-CD3 ANTIBODIES AND METHODS OF USE
#506PCI method for generating immune respose to antigenic molecule using checkpoint inhibitor and TLR3 ligand
#507Parathyroid hormone receptor 1 (PTH1R) antibodies and uses thereof
#508Combination therapy for treatment of coronary artery disease
#509Aortopathy
#510Methods for treating or preventing asthma by administering an IL-4R antagonist
#511In Vivo Activation of Antigen Presenting Cells for Enhancement of Immune Responses Induced by Virus-Like Particles
#512Methods for upregulating immune responses using combinations of anti-RGMb and anti-PD-1 agents
#513Combination tumor immunotherapy
#514Anti-CD47 antibodies and uses thereof
#515Method of treating cancer with a multiple integrin binding Fc fusion protein
#516DIAGNOSING AND TREATING IGA NEPHROPATHY
#517Combination immune therapy and cytokine control therapy for cancer treatment
#518Anti-GITR antibodies and uses thereof
#519TREATMENT OF OCULAR DISORDERS
#520METHODS FOR TREATING NEURODEGENERATIVE DISEASES
#521Treatment of pediatric BCP-ALL patients with an anti-KIR antibody
#522Combination therapies of HDAC inhibitors and PD-1 inhibitors
#523Composition to induce bone marrow stem cell mobilization
#524Antigen binding proteins that bind PD-L1
#525Antibodies to TIGIT
#526Approach for treatment of cancer via immunomodulation by using talabostat
#527Methods and compositions for enhancing the potency of superantigen mediated cancer immunotherapy
#528Localized immunosuppression of allografts for peripheral nerve repair
#529Priming of pancreatic tumor cells and cancer stem cells to TRAIL-induced apoptosis
#530Methods of treating inflammatory and autoimmune diseases with natalizumab
#531Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
#532Therapy-enhancing glucan
#533Therapeutic use of anti-CD22 antibodies for inducing trogocytosis
#534COMPOSITIONS AND METHODS FOR TREATMENT OF SICKLE CELL DISEASE
#535Anti-CTLA4 monoclonal antibody or its antigen binding fragments, pharmaceutical compositions and uses
#536SYNERGISTIC TUMOR TREATMENT WITH IL-2, A THERAPEUTIC ANTIBODY, AND AN IMMUNE CHECKPOINT BLOCKER
#537Anti-PDGFR-beta antibodies and uses thereof
#538Classifiers of NF-κB pathway activation, devices, and methods of use thereof
#539Therapeutic method and medicament for HTLV-1 associated myelopathy
#540Depletion of plasmacytoid dendritic cells
#541Combined therapy of alpha-1-antitrypsin and temporal T-cell depletion for preventing graft rejection
#542Antigen Binding Proteins that Bind PD-L1
#543Depletion of plasmacytoid dendritic cells
#544HUMAN ANTIBODIES AND ANTIBODY-DRUG CONJUGATES AGAINST CD74
#545METHODS AND COMPOSITIONS FOR INDUCTION OF UCP1 EXPRESSION
#546Combination therapy for cancer
#547Methods of treating autoimmune diseases
#548SELECTIVE SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS AND COMBINATION THERAPY THEREWITH
#549THERAPIES BASED ON CONTROL OF REGULATORY T CELL STABILITY AND FUNCTION VIA A NEUROPILIN-1:SEMAPHORIN AXIS
#550KV1.3 binding immunoglobulins
#551Compositions and methods to activate or inhibit toll-like receptor signaling
#552Human antibodies to the glucagon receptor and methods of use thereof for lowering blood glucose or ketone levels
#553Use of vista agonists and antagonists to suppress or enhance humoral immunity
#554Combined organ and hematopoietic cells for transplantation tolerance of grafts
#555Use of negative functional modulators of erythropoietin for therapy
#556Combined organ and hematopoietic cells for transplantation tolerance of HLA mismatched grafts
#557Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist of TIM-3
#558Method and system for preventing migraine headaches, cluster headaches and dizziness
#5592,3-disubstituted pyridine compounds as TGF-beta inhibitors and methods of use
#560METHODS USING 3-(4-AMINO-1-OXO-1,3-DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE FOR TREATMENT OF CERTAIN LEUKEMIAS
#561Antibody fragments against the insulin receptor and uses thereof to treat hypoglycemia
#562Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
#563METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES WITH NATALIZUMAB
#564KIT FOR MONITORING, DETECTING AND STAGING GVHD
#565Methods of treating multiple sclerosis using anti-CD20 antibodies
#566Compositions and methods for inhibiting arginase activity
#567Purification of functional human astrocytes
#568CD37-binding molecules and immunoconjugates thereof
#569Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody
#570Vaccines against HPV and HPV-related diseases
#571Depletion of plasmacytoid dendritic cells
#572Molecules that bind CD180, compositions and methods of use
#573Adjuvant combinations comprising alpha-galactosylceramide or iGb3, CD40 agonists and antigen
#574Fc-free antibodies comprising two fab-fragments and methods of use
#575Immunostimulatory combinations
#576Anti-PDGFR-beta antibodies and uses thereof
#577COMBINATION THERAPY WITH IL-12
#578Anti-LAG-3 binding proteins
#579Therapeutic methods using anti-CD200 antibodies
#580Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
#581Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
#582Treatment of ocular disorders
#583Composition of anti-ENDO180 antibodies and methods of use for the treatment of cancer and fibrotic diseases
#584GLA monotherapy for use in cancer treatment
#585Method of inducing senescence in tumor cells by administrating TNF-a in combination with IFNa or IFNy
#586Human antibodies to the glucagon receptor and methods of use thereof
#587Compositions and methods including a recombinant human MAB that promotes CNS remyelination
#588Methods for predicting the sensitivity of a subject to immunotherapy
#589Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
#590Methods for treating GI syndrome and graft versus host disease
#591Anti-KIR antibodies, formulations, and uses thereof
#592Modulation of yeast-based immunotherapy products and responses
#593COMBINATION THERAPY
#594Aminoacyl tRNA synthetases for modulating inflammation
#595PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING TYPE I DIABETES AND APPLICATION THEREOF
#596Human Antibodies and Specific Binding Sequences Thereof for use in Stroke and Ischemia or Ischemic Conditions
#597Methods and compositions to regulate hepcidin expression
#598Combination therapy for the treatment of glioblastoma
#599Method of treating motor neuron disease with an antibody that agonizes MuSK
#600Methods of treating autoimmune diseases